
Third-Party Tested by Verum Analytics
CJC-1295 No DAC
GHRH analog research peptide (Modified GRF 1-29) without Drug Affinity Complex.
Third-Party Tested by Verum Analytics

Albert's Verdict
Without the DAC modification, CJC-1295 delivers a sharper, more physiological pituitary pulse — the half-life stays closer to endogenous GHRH patterns. Useful when research design calls for pulse rather than sustained elevation.
View COA✓ In stock - Ships same day
Arrives as lyophilized (powder) form
Shipped freeze-dried for maximum stability and shelf life. See laboratory preparation guide for handling instructions.
Product Description
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic GHRH analog comprising the first 29 amino acids of native GHRH. Substitutions at positions 2, 8, 15, and 27 confer resistance to enzymatic degradation in laboratory research models, extending the analog's biological half-life while preserving GHRH-receptor pathway research applicability.
Molecular Profile:
- Molecular Weight: 3,367.9 g/mol
- Sequence: Modified GRF (1-29) with D-Ala², Gln⁸, Ala¹⁵, Leu²⁷ substitutions
- CAS Number: 863288-34-0
Research Applications:
- GHRH-receptor binding and signaling research
- Pulsatile GHRH-axis pathway research models
- IGF-1 axis cellular research models
- Receptor half-life and degradation-resistance research
Quality Standards:
- Purity: ≥99% verified by HPLC
- Third-party tested with COA included
For laboratory handling instructions, refer to the Preparation Guide.
FOR RESEARCH AND LABORATORY USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Technical Specifications
- Molecular Formula
- C152H252N44O42
- Molecular Weight
- 3367.97 g/mol
- Sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Frequently Researched Together
Commonly studied alongside in laboratory settings
Research FAQ — CJC-1295 No DAC
Frequently asked questions about this compound for laboratory researchers.
What is CJC-1295 No DAC and how is it different from CJC-1295 DAC?+
What is the reported half-life of CJC-1295 No DAC?+
Is CJC-1295 No DAC frequently studied alongside Ipamorelin in research?+
How should CJC-1295 No DAC be stored?+
Published research references
Peer-reviewed literature relevant to CJC-1295 No DAC research. Linked PubMed IDs open the original source.
- [1]Sustained-release GH releasing factor (CJC-1295) for hormone studies — J Clin Endocrinol Metab (2006) · PMID 16384879
- [2]Effects of CJC-1295 in human GH-deficient adults — J Clin Endocrinol Metab (2006) · PMID 16352683
- [3]GHRH analogs and growth hormone pulsatility — Endocr Rev (2012) · PMID 22148949
Learn More About This Peptide
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.